[logo] HealthTree Foundation
more_vert

Innovations in High-Risk MDS: Expert Insights with Dr. Jacqueline Garcia

Innovations in High-Risk MDS: Expert Insights with Dr. Jacqueline Garcia image

Innovations in High-Risk MDS: Expert Insights with Dr. Jacqueline Garcia

Webinar
event Apr 29, 2026 / 10:30AM - 11:30AM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Join Dr. Jacqueline Garcia of the Dana-Farber Cancer Institute for an essential update on the rapidly evolving treatment landscape for High-Risk MDS. This webinar will break down the latest clinical innovations, including promising combination therapies and targeted oral treatments, into clear and actionable insights. Whether you are newly diagnosed or exploring new options, you’ll gain the expert knowledge needed to navigate high-risk care with confidence.

Schedule & Agenda

The panelist Dalton Bean
10:30 AM
Introduction
Dalton Bean

Dalton introduces the agenda for the event and our featured speaker Dr. Jacqueline Garcia

Event panelist Audience
11:05 AM
Questions and Answers
Audience

Come with your questions and experiences to share with the group!

The panelist Jaqueline Garcia, MD
10:35 AM
Presentation
Jaqueline Garcia, MD

Dr. Garcia talks about high risk MDS

Speakers & Moderators

The panelist Dalton Bean
Dalton Bean
Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio
The panelist Jaqueline Garcia, MD
Jaqueline Garcia, MD

Dr. Jacqueline S. Garcia is a medical oncologist in the Adult Leukemia Program at the Dana-Farber Cancer Institute. She graduated from University of Illinois at Chicago College of Medicine and completed her internship and residency training in Internal Medicine at the University of Chicago. She next completed Hematology and Oncology Fellowship training at Stanford University. Dr. Garcia’s research focus is on the design and execution of scientifically-based early phase clinical and proof-of-concept studies in advanced myeloid malignancies, including myelodysplastic syndromes, myelofibrosis and acute myeloid leukemia. Much of her research centers on identifying novel therapeutic opportunities to leverage the anti-apoptotic pathway in chemoresistant leukemia and developing investigator-initiated trials.  Her research is supported by awards from the National Institutes of Health/National Cancer Institute, Leukemia and Lymphoma Society, and Conquer Cancer Foundation.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Myelodysplastic Syndromes Discussion group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the Latest Myelodysplastic Syndromes Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Together we care.

Together we cure.

100% of every dollar you give supports our life-changing mission.